Genetic testing company 23andMe filed for bankruptcy in the United States, raising concerns about the fate of highly sensitive genetic data from its 15 million customers. The company, best known for its at-home DNA testing kits, has stated that it will continue to operate and will not change the
The recent bankruptcy filing of 23andMe, a front-runner in direct-to-consumer genetic testing, has sparked a wave of concerns regarding the privacy and security of sensitive genetic data from over 15 million customers. This development has shone a light on the implications of corporate financial
A groundbreaking statistic reveals that the global AI in healthcare market is projected to reach $45.2 billion by the end of the next decade. As advanced technologies emerge, the integration of AI in healthcare continues to expand. However, several challenges still inhibit the seamless adoption of
The transformative potential of artificial intelligence (AI) in healthcare is undeniable. AI promises to revolutionize patient care with advanced diagnostic tools, predictive analytics, and streamlined administrative processes. However, the rapid pace of innovation raises critical questions about
Virtual reality (VR) is making waves in the field of mental health, offering new possibilities for treating conditions like anxiety and stress. The immersive nature of VR creates controlled environments that can aid therapeutic processes by tricking the brain into feeling present in these virtual
With the Regulation on the European Health Data Space (EHDS) now published in the Official Journal on March 5, 2025, a significant transformation in the access and use of health data across Europe is on the horizon. The EHDS is set to be implemented in stages over several years, with the secondary
